Human medicines European public assessment report (EPAR): Comtess, entacapone, Parkinson Disease, Date of authorisation: 16/09/1998, Revision: 26, Status: Authorised

Human medicines European public assessment report (EPAR): Rivastigmine Hexal, rivastigmine, Dementia,Alzheimer Disease,Parkinson Disease, Date of authorisation: 11/12/2009, Revision: 10, Status: Authorised

Case Medical Research ◽

10.31525/cmr-1930425 ◽

2019 ◽

Author(s):

Keyword(s):

Alzheimer Disease ◽

Parkinson Disease ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Pramipexole Teva, pramipexole, Parkinson Disease, Date of authorisation: 18/12/2008, Revision: 19, Status: Authorised

Case Medical Research ◽

10.31525/cmr-1e4edd3 ◽

2019 ◽

Author(s):

Keyword(s):

Parkinson Disease ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Oprymea, pramipexole, Parkinson Disease, Date of authorisation: 12/09/2008, Revision: 19, Status: Authorised

Case Medical Research ◽

10.31525/cmr-22c8398 ◽

2019 ◽

Author(s):

Keyword(s):

Parkinson Disease ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Xadago, safinamide, Parkinson Disease, Date of authorisation: 23/02/2015, Revision: 9, Status: Authorised

Case Medical Research ◽

10.31525/cmr-4ac53b ◽

2019 ◽

Author(s):

Keyword(s):

Parkinson Disease ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Entacapone Orion, entacapone, Parkinson Disease, Date of authorisation: 18/08/2011, Revision: 8, Status: Authorised

Case Medical Research ◽

10.31525/cmr-1ee8d04 ◽

2019 ◽

Author(s):

Keyword(s):

Parkinson Disease ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Oprymea, pramipexole, Parkinson Disease, Date of authorisation: 12/09/2008, Revision: 19, Status: Authorised

Case Medical Research ◽

10.31525/cmr-22d32fa ◽

2019 ◽

Author(s):

Keyword(s):

Parkinson Disease ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Ongentys, opicapone, Parkinson Disease, Date of authorisation: 24/06/2016, Revision: 2, Status: Authorised

Case Medical Research ◽

10.31525/cmr-116deed ◽

2019 ◽

Author(s):

Keyword(s):

Parkinson Disease ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Comtan, entacapone, Parkinson Disease, Date of authorisation: 22/09/1998, Revision: 24, Status: Authorised

Case Medical Research ◽

10.31525/cmr-24ad82c ◽

2019 ◽

Author(s):

Keyword(s):

Parkinson Disease ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Mirapexin, pramipexole, Restless Legs Syndrome,Parkinson Disease, Date of authorisation: 23/02/1998, Revision: 34, Status: Authorised

Case Medical Research ◽

10.31525/cmr-1336904 ◽

2019 ◽

Author(s):

Keyword(s):

Parkinson Disease ◽

Restless Legs Syndrome ◽

Assessment Report ◽

Restless Legs ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Stalevo, levodopa / carbidopa / entacapone, Parkinson Disease, Date of authorisation: 17/10/2003, Revision: 24, Status: Authorised

Case Medical Research ◽

10.31525/cmr-d6cc86 ◽

2019 ◽

Author(s):

Keyword(s):

Parkinson Disease ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text